Creatinine Clearance (Cockcroft-Gault) Calculator
Calculate creatinine clearance for renal function assessment and drug dosing adjustment in patients with renal impairment using the Cockcroft-Gault equation with optional IBW/ABW adjustment for obese patients.
CLINICAL USE DISCLAIMER
This calculator is for healthcare professional reference only. Results must be interpreted in the context of complete patient assessment. Drug dosing decisions should consider additional factors including renal function trends, concurrent medications, and patient-specific considerations. Always consult drug-specific dosing guidelines and clinical judgment.
Embed This Calculator on Your Website
Add this free calculator to your blog, website, or CMS with a simple copy-paste embed code.
Introduction
Kidney function determines the safe dosing of more than 200 commonly prescribed medications. When renal function is impaired, drugs that rely on renal elimination accumulate to toxic levels if doses are not adjusted. The Cockcroft-Gault equation, published in 1976 and validated in clinical practice for nearly 50 years, remains the standard method for estimating creatinine clearance (CrCl) in clinical pharmacology and drug dosing decisions. According to the FDA's guidance on pharmacokinetics in patients with impaired renal function, CrCl is the recommended measure for dose adjustment calculations for most renally-cleared drugs. Misestimating renal function is not an academic error. Gentamicin, vancomycin, metformin, digoxin, and direct oral anticoagulants all require CrCl-based dose adjustments. An incorrect CrCl calculation on a 78-year-old patient with a normal serum creatinine of 1.0 mg/dL, but actual reduced kidney function due to low muscle mass, can result in a 30% to 50% dose error.
What This Calculator Does
This calculator estimates creatinine clearance using the Cockcroft-Gault equation, which requires age, weight (actual body weight), sex, and serum creatinine. It outputs estimated CrCl in mL/min and classifies renal function according to the NKF-KDIGO staging framework: Normal (CrCl above 90), Mildly Reduced (60 to 89), Moderately Reduced (30 to 59), Severely Reduced (15 to 29), and Kidney Failure (below 15). The calculator notes weight considerations for obese patients where ideal body weight or adjusted body weight may be clinically appropriate, and flags when CrCl may be unreliable (very low or high muscle mass, rapidly changing creatinine, pregnancy).
The Formula
The Cockcroft-Gault equation estimates glomerular filtration by modeling the relationship between age, body weight, serum creatinine, and sex. Age reflects the age-related decline in nephron number and GFR (approximately 1 mL/min/year after age 40). Weight accounts for muscle mass as the primary source of creatinine production. The denominator normalizes by 72 (an empirically derived constant from the original study). The 0.85 female correction factor accounts for lower average muscle mass in women, which reduces creatinine production relative to men of the same weight. Serum creatinine is the primary lab input: higher creatinine indicates less efficient renal elimination. Important: Cockcroft-Gault uses actual body weight (ABW) for non-obese patients, ideal body weight (IBW) for obese patients (>30% above IBW), and adjusted body weight (AdjBW = IBW + 0.4 × (ABW - IBW)) for some clinical applications.
Step-by-Step Example
Collect required patient parameters
Age: 74 years. Sex: Male. Weight: 68 kg (actual body weight; within 30% of IBW for this height, so ABW is used). Serum creatinine: 1.4 mg/dL (from most recent lab within 24 to 48 hours, while patient is in steady state).
Apply the Cockcroft-Gault equation
CrCl = [(140 - 74) × 68] / [72 × 1.4] = [66 × 68] / [100.8] = 4,488 / 100.8 = 44.5 mL/min. Male patient: no 0.85 correction factor needed.
Classify renal function stage
CrCl 44.5 mL/min = Moderately Reduced Renal Function (Stage 3 CKD, CrCl 30 to 59). This triggers dose adjustment requirements for drugs including metformin (hold if CrCl below 30), direct oral anticoagulants, and all aminoglycosides.
Apply drug dose adjustment guidance
For this patient on apixaban (Eliquis): standard dose 5 mg twice daily. FDA prescribing information criteria for dose reduction to 2.5 mg twice daily: two of three criteria (age 80+, weight 60 kg or less, SCr 1.5 mg/dL or higher). This patient meets only age 74 (below 80 threshold). Standard 5 mg dose is appropriate. The renal stage calculation informs the clinical decision, but drug-specific criteria must always be cross-referenced.
Real-World Use Cases
Pre-Procedure Metformin Management
A clinical pharmacist reviewing a 66-year-old female patient's medications before a contrast CT calculates CrCl: [(140 - 66) × 58 kg] / [72 × 1.1] = 54.0 mL/min. CrCl is between 30 and 60 mL/min (moderately reduced). Per FDA guidance updated in 2016, metformin can be continued for CrCl 30 to 45 mL/min with increased monitoring but should be held 48 hours before contrast administration for CrCl below 60 mL/min per institutional protocols. The calculation triggers the necessary pre-procedure metformin hold order.
Vancomycin Initial Dosing for Renally-Impaired Patient
A 62-year-old male, 84 kg, SCr 2.1 mg/dL, admitted with MRSA bacteremia requires vancomycin. CrCl = [(140 - 62) × 84] / [72 × 2.1] = 43.1 mL/min. This severely reduces vancomycin elimination, extending the dosing interval. Without CrCl calculation, using standard 1g every 12 hours would lead to drug accumulation and nephrotoxicity. The CrCl drives the pharmacokinetic model to an extended 24 to 36-hour interval.
Low-Muscle-Mass Elderly Patient Assessment
An 82-year-old female, 46 kg, SCr 0.7 mg/dL (appears normal by standard lab reference range). CrCl = [(140 - 82) × 46] / [72 × 0.7] × 0.85 = 28.4 mL/min. Despite a normal-appearing serum creatinine, CrCl is severely reduced. This is the most clinically dangerous scenario: providers who see a normal creatinine assume normal renal function and miss necessary dose reductions. The Cockcroft-Gault calculation is mandatory, not optional, in elderly low-body-weight patients.
Comparison
| CrCl Range (mL/min) | Renal Function Stage | CKD Stage | Clinical Action |
|---|---|---|---|
| Above 90 | Normal | Stage 1 (with other markers) | Standard dosing |
| 60-89 | Mildly Reduced | Stage 2 | Monitor; adjust select drugs |
| 30-59 | Moderately Reduced | Stage 3 | Dose reduction required for many drugs |
| 15-29 | Severely Reduced | Stage 4 | Significant dose adjustments; avoid nephrotoxins |
| Below 15 | Kidney Failure | Stage 5 | Dialysis dosing protocols; nephrology consult |
Common Mistakes to Avoid
Assuming a normal serum creatinine means normal renal function in elderly or cachectic patients. Serum creatinine reflects the balance between creatinine production (proportional to muscle mass) and elimination (proportional to renal function). An 80-year-old with low muscle mass produces very little creatinine, so a SCr of 0.8 mg/dL may reflect CrCl of only 25 to 35 mL/min. Calculation is mandatory.
Using actual body weight for obese patients without adjustment. The Cockcroft-Gault equation was derived in a primarily non-obese patient population. For patients whose actual body weight exceeds ideal body weight by more than 30%, using ABW overestimates CrCl because fat tissue contributes little to creatinine production. Use adjusted body weight (AdjBW = IBW + 0.4 × [ABW - IBW]) for obese patients.
Using a serum creatinine value collected during an acute kidney injury (AKI) event. Cockcroft-Gault assumes steady-state creatinine. During AKI, creatinine is rising rapidly and does not reflect current GFR. Using a rising creatinine in the equation overestimates CrCl. During AKI, pharmacokinetic monitoring (drug levels) is more reliable than equation-based estimates.
Confusing Cockcroft-Gault CrCl with eGFR from the CKD-EPI equation. The CKD-EPI equation (reported by most clinical labs as eGFR) is normalized to a body surface area of 1.73 m2 and is preferred for CKD staging. Cockcroft-Gault is not body-surface-area-adjusted and is preferred for drug dosing. They are not interchangeable. Using CKD-EPI eGFR in place of Cockcroft-Gault CrCl for dose adjustments can cause dosing errors.
Frequently Asked Questions
Accuracy and Disclaimer
This calculator is a clinical decision support tool based on the Cockcroft-Gault equation as published by Cockcroft and Gault (1976) and recommended by the FDA for renal dosing adjustments. Results are estimates and must be interpreted by a qualified healthcare professional in the context of the individual patient's clinical status. This tool does not replace clinical judgment, therapeutic drug monitoring, or consultation with a clinical pharmacist or nephrologist. Drug dosing decisions must reference current prescribing information for each specific medication. This calculator is not intended for use in pediatric patients, pregnancy, or acute kidney injury without specialist review.
Conclusion
Creatinine clearance estimation using Cockcroft-Gault is a foundational skill in clinical pharmacy. The result must always be interpreted in clinical context, not applied mechanically. For patients on vancomycin, combine this CrCl estimate with the AUC-Based Vancomycin Dosing Calculator to determine individualized dosing regimens. For patients on multiple renally-cleared medications, use the Drug Interaction Severity Reference to identify potential nephrotoxic combinations that could further impair renal function and require additional monitoring.
Related Pharmacy & Clinical Pharmacology Calculators
AUC-Based Vancomycin Dosing Calculator
Calculate vancomycin dosing using 2020 ASHP/IDSA/SIDP AUC-guided monitoring guidelines with empiric first-dose and Bayesian two-level adjustment methods targeting AUC 400-600 mg·h/L.
Use CalculatorPharmacy & Clinical PharmacologyPharmacy Compounding Cost Calculator
Calculate accurate compounding prices including ingredient costs, pharmacist/technician labor, overhead allocation, supplies, profit margin, and dispensing fees for custom pharmaceutical preparations.
Use CalculatorPharmacy & Clinical PharmacologyDrug Interaction Severity Reference
Lexi-Interact severity classification reference (Risk Ratings A through X) with common high-risk drug interactions, clinical significance, and management recommendations for pharmacy practice.
Use CalculatorPharmacy & Clinical PharmacologyMedication Adherence Rate Calculator
Calculate medication adherence using PDC (Proportion of Days Covered), MPR, or pill count methods with CMS Star Rating threshold analysis and MTM intervention recommendations.
Use CalculatorYou May Also Find Useful
Tax Calculator
Estimate your 2026 federal income tax based on filing status, gross income, deductions, and current tax brackets. See your marginal and effective tax rates instantly.
Use CalculatorFinance & AccountingSalary to Hourly Calculator
Convert your annual salary to an hourly wage instantly. Adjust for hours per week, weeks per year, and overtime to find your true hourly rate.
Use CalculatorFinance & AccountingCommission Calculator
Determine sales commissions based on revenue, rate tiers, and bonus structures.
Use Calculator